1. Home
  2. J vs ALGN Comparison

J vs ALGN Comparison

Compare J & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jacobs Solutions Inc.

J

Jacobs Solutions Inc.

HOLD

Current Price

$123.13

Market Cap

13.4B

Sector

Industrials

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$170.66

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
J
ALGN
Founded
1947
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4B
12.7B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
J
ALGN
Price
$123.13
$170.66
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
$154.60
$199.82
AVG Volume (30 Days)
1.4M
881.2K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
1.15%
N/A
EPS Growth
N/A
0.53
EPS
0.79
1.57
Revenue
$14,984,646,000.00
$387,126,000.00
Revenue This Year
$12.96
$5.78
Revenue Next Year
N/A
$4.62
P/E Ratio
$155.65
$108.13
Revenue Growth
49.51
23.95
52 Week Low
$105.68
$122.00
52 Week High
$168.44
$208.31

Technical Indicators

Market Signals
Indicator
J
ALGN
Relative Strength Index (RSI) 56.56 51.92
Support Level $105.68 $164.49
Resistance Level $131.94 $174.67
Average True Range (ATR) 4.38 5.80
MACD 1.26 1.74
Stochastic Oscillator 95.09 74.35

Price Performance

Historical Comparison
J
ALGN

About J Jacobs Solutions Inc.

Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $12 billion in revenue in fiscal 2025.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: